Eli Lilly and Company raised earnings guidance for the year 2024. For the year, the company expects revenue of $42.4 billion to $43.6 billion against previous guidance of $40.4 billion to $41.6 billion. Earnings per Share (reported) of $13.05 to $13.55 against previous guidance of $11.80 to $12.30.
Market Closed -
Other stock markets
|
Pre-market 09:03:47 | |||
771.6 USD | -1.96% | 773.7 | +0.28% |
10:54am | Roche: share price stands out, Deutsche Bank in support | CF |
05-16 | Health Care Flat as Momentum Wanes -- Health Care Roundup | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.36% | 694B | |
+29.81% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.60% | 239B | |
-3.39% | 209B | |
+10.25% | 209B | |
+9.27% | 169B | |
+0.45% | 164B |
- Stock Market
- Equities
- LLY Stock
- News Eli Lilly and Company
- Eli Lilly and Company Raises Earnings Guidance for the Year 2024